| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An analysis of FDA-approved drugs for psychiatric disorders
|
Kinch, Michael S.
|
|
2015
|
20 |
3 |
p. 292-295
4 p.
|
artikel
|
| 2 |
A new application of value-stream mapping in new drug development: a case study within Novartis
|
Heinzen, Mareike
|
|
2015
|
20 |
3 |
p. 301-305
5 p.
|
artikel
|
| 3 |
Beyond biomarkers in drug discovery and development
|
Steensberg, Adam
|
|
2015
|
20 |
3 |
p. 289-291
3 p.
|
artikel
|
| 4 |
Contents page 1
|
|
|
2015
|
20 |
3 |
p. i-
1 p.
|
artikel
|
| 5 |
Contents page 2
|
|
|
2015
|
20 |
3 |
p. iii-
1 p.
|
artikel
|
| 6 |
Emerging therapeutic strategies in COPD
|
Babu, Kesavan S.
|
|
2015
|
20 |
3 |
p. 371-379
9 p.
|
artikel
|
| 7 |
Machine-learning approaches in drug discovery: methods and applications
|
Lavecchia, Antonio
|
|
2015
|
20 |
3 |
p. 318-331
14 p.
|
artikel
|
| 8 |
PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma
|
Puttick, Simon
|
|
2015
|
20 |
3 |
p. 306-317
12 p.
|
artikel
|
| 9 |
Quantitative high-throughput screening data analysis: challenges and recent advances
|
Shockley, Keith R.
|
|
2015
|
20 |
3 |
p. 296-300
5 p.
|
artikel
|
| 10 |
Racing to define pharmaceutical R&D external innovation models
|
Wang, Liangsu
|
|
2015
|
20 |
3 |
p. 361-370
10 p.
|
artikel
|
| 11 |
Recent advances in controlled pulmonary drug delivery
|
Liang, Zhenglin
|
|
2015
|
20 |
3 |
p. 380-389
10 p.
|
artikel
|
| 12 |
Splice variants in the proteome: a promising and challenging field to targeted drug discovery
|
Tavares, Raphael
|
|
2015
|
20 |
3 |
p. 353-360
8 p.
|
artikel
|
| 13 |
Target identification and validation in brain reward dysfunction
|
Alguacil, Luis F.
|
|
2015
|
20 |
3 |
p. 347-352
6 p.
|
artikel
|
| 14 |
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives
|
Lv, Meng
|
|
2015
|
20 |
3 |
p. 332-346
15 p.
|
artikel
|
Tijdschrift beschrijving